News

(Bloomberg) -- Beleaguered stock bulls are getting an encouraging sign from the people who know the companies best.Most Read from BloombergHow Did This Suburb Figure Out Mass Transit?Trump Signs Executive Orders on Federal Purchasing, Office SpaceLA County Floats Leaner Budget Burdened by Fire and Legal CostsCorporate insiders scooped up shares of their own companies at the fastest pace in 16 months as the S&P 500 sank in March, and they kept buying at an elevated clip as the rout accelerated th

The secretive nature of Booz Allen’s government work makes it nearly impossible for investors to gauge how federal cutbacks will affect the business.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Genco (NYSE:GNK) and its peers.

LifeStance Health Group trades at $6.79 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 7.1% while the S&P 500 is down 8.3%. This may have investors wondering how to approach the situation.

Let’s dig into the relative performance of IAC (NASDAQ:IAC) and its peers as we unravel the now-completed Q4 digital media & content platforms earnings season.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Veeva Systems (NYSE:VEEV) and the best and worst performers in the vertical software industry.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.